AI assistant
CYTOKINETICS INC — Director's Dealing 2011
Jan 4, 2011
30870_dirs_2011-01-04_3854c188-061d-44ca-abb6-9e1d1fae0e55.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2011-01-03
Reporting Person: GAGE L PATRICK (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-03 | Non-Qualified Stock Option (right to buy) | $2.16 | A | 46296 | Acquired | 2021-01-03 | Common Stock (46296) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $2.81 | 2020-05-20 | Common Stock (20000) | 20000 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.33 | 2019-11-05 | Common Stock (30000) | 30000 | Direct |
Footnotes
F1: This option shall vest and become exercisable as to 46,296 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2012.
F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual retainer of $40,000.
F3: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 20, 2011.
F4: This option shall vest and become exercisable as to 833 shares on 12/05/09 and the balance of 29,167 divided into equal monthly installments thereafter such that the option shall be 100% vested on 11/05/12.